| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |